Auswahl der wissenschaftlichen Literatur zum Thema „Surveillance immune“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Surveillance immune" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Surveillance immune"
Shastri, Nilabh, Chansu Park und Jian Guan. „Immune surveillance of immune surveillance“. Molecular Immunology 150 (Oktober 2022): 2. http://dx.doi.org/10.1016/j.molimm.2022.05.018.
Der volle Inhalt der QuelleSwann, Jeremy B., und Mark J. Smyth. „Immune surveillance of tumors“. Journal of Clinical Investigation 117, Nr. 5 (01.05.2007): 1137–46. http://dx.doi.org/10.1172/jci31405.
Der volle Inhalt der QuelleGrossman, Zvi, und Ronald B. Herberman. „‘Immune surveillance’ without immunogenicity“. Immunology Today 7, Nr. 5 (Mai 1986): 128–31. http://dx.doi.org/10.1016/0167-5699(86)90075-7.
Der volle Inhalt der QuellePrehn, Richmond T., und Liisa M. Prehn. „The flip side of immune surveillance: immune dependency“. Immunological Reviews 222, Nr. 1 (April 2008): 341–56. http://dx.doi.org/10.1111/j.1600-065x.2008.00609.x.
Der volle Inhalt der QuelleKim, Ryungsa, Manabu Emi und Kazuaki Tanabe. „Cancer immunoediting from immune surveillance to immune escape“. Immunology 121, Nr. 1 (Mai 2007): 1–14. http://dx.doi.org/10.1111/j.1365-2567.2007.02587.x.
Der volle Inhalt der QuelleSchaller, Julien, und Judith Agudo. „Metastatic Colonization: Escaping Immune Surveillance“. Cancers 12, Nr. 11 (16.11.2020): 3385. http://dx.doi.org/10.3390/cancers12113385.
Der volle Inhalt der QuelleLowe, Scott. „Immune Surveillance of Senescent Cells“. Innovation in Aging 5, Supplement_1 (01.12.2021): 246. http://dx.doi.org/10.1093/geroni/igab046.952.
Der volle Inhalt der QuelleAhmad, Aamir. „Tumor microenvironment and immune surveillance“. Microenvironment and Microecology Research 4, Nr. 1 (2022): 6. http://dx.doi.org/10.53388/mmr2022006.
Der volle Inhalt der QuelleOh, Julia, und Derya Unutmaz. „Immune cells for microbiota surveillance“. Science 366, Nr. 6464 (24.10.2019): 419–20. http://dx.doi.org/10.1126/science.aaz4014.
Der volle Inhalt der QuelleZanetti, M., und N. R. Mahadevan. „Immune Surveillance from Chromosomal Chaos?“ Science 337, Nr. 6102 (27.09.2012): 1616–17. http://dx.doi.org/10.1126/science.1228464.
Der volle Inhalt der QuelleDissertationen zum Thema "Surveillance immune"
Rosenthal, Rachel Suzanne. „Immune editing and surveillance in cancer evolution“. Thesis, University College London (University of London), 2018. http://discovery.ucl.ac.uk/10047362/.
Der volle Inhalt der QuelleSCHEIDECKER, CATHERINE. „Cellule nk : surveillance immune et resistance naturelle“. Strasbourg 1, 1987. http://www.theses.fr/1987STR10724.
Der volle Inhalt der QuelleMarri, Eswari. „Immune surveillance of activated immune and tumour cells by surfactant protein D“. Thesis, Brunel University, 2015. http://bura.brunel.ac.uk/handle/2438/13847.
Der volle Inhalt der QuelleKaur, Anuvinder. „Innate immune surveillance in ovarian and pancreatic cancer“. Thesis, Brunel University, 2017. http://bura.brunel.ac.uk/handle/2438/15847.
Der volle Inhalt der QuelleCheung, Ann F. „Investigating immune surveillance, tolerance, and therapy in cancer“. Thesis, Massachusetts Institute of Technology, 2009. http://hdl.handle.net/1721.1/46809.
Der volle Inhalt der QuelleThis electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.
Vita.
Includes bibliographical references.
Maximizing the potential of cancer immunotherapy requires model systems that closely recapitulate human disease to study T cell responses to tumor antigens and to test immune therapeutic strategies. Current model systems largely relied on chemically-induced and spontaneous tumors in immunodeficient mice or on transplanted tumors. Such systems are limited because they fail to reproduce the complex interactions that exist among an emerging tumor, its microenvironment and the multiple elements of an intact immune system. We created a new system that is compatible with Cre-loxP-regulatable mouse cancer models in which the defined antigen SIY is specifically over-expressed in tumors, mimicking clinically-relevant tumor-associated antigens. To demonstrate the utility of this system, we characterized SIYreactive T cells in the context of lung adenocarcinoma, revealing multiple levels of antigenspecific T cell tolerance that serve to limit an effective anti-tumor response. Thymic deletion reduced the number of SIY-reactive T cells present in the animals. When potentially self-reactive T cells in the periphery were activated, they were efficiently eliminated. Inhibition of apoptosis resulted in more persistent self-reactive T cells, but these cells became anergic to antigen stimulation. Finally, in the presence of tumors over- expressing SIY, SIY-specific T cells required a higher level of costimulation to achieve functional activation.
(cont.) Adoptive cell transfer (ACT) therapy for cancer has demonstrated tremendous efficacy in clinical trials, particularly for the treatment of metastatic melanoma. There is great potential in broadening the application of ACT to treat other cancer types, but the threat of severe autoimmunity may limit its use. Studies in other model systems have demonstrated successful induction of anti-tumor immunity against self-antigens without detrimental autoimmunity. This is possibly due to the preferential recognition of tumor over normal somatic tissue by activated T cells. In our system, SIY provides a means to achieve this bias because of its over-expression in tumors. Thus, we applied adoptive T cell transfer therapy combined with lymphodepleting preconditioning to treat autochthonous lung tumors over-expressing SIY self-antigen. With this treatment, we overcame peripheral tolerance, successfully inducing large number of functional anti-tumor T cells. These T cells are able to influence lung tumors over-expressing self-antigen. Importantly, despite large numbers of potentially self-reactive T cells, we did not observed overt autoimmunity. Immune tolerance thwarts efforts to utilize immune therapy against cancer. We have discerned many mechanisms by which tolerance to cancer in potential achieved. Both Foxp3+ T regulatory cell and myeloid-derived suppressor cell populations are expanded in the presence of cancer in our mouse models.
(cont.) In addition, we identified LAG-3 as a potential factor that serves to limit anti-tumor T cell activity in the context of adoptive cell transfer therapy. Our new system represents a valuable tool in which to explore the mechanisms that contribute to T cell tolerance to cancer and to evaluate therapies aimed at overcoming this tolerance. In addition, our model provides a platform, on which more advanced mouse models of human cancer can be generated for cancer immunology.
by Ann F. Cheung.
Ph.D.
Loughhead, Scott McNabb. „Immune Surveillance by Effector and Memory CD8+ T Cells“. Thesis, Harvard University, 2016. http://nrs.harvard.edu/urn-3:HUL.InstRepos:26718721.
Der volle Inhalt der QuelleMedical Sciences
Sowinski, Stefanie. „Transmission and immune surveillance of human T cell-tropic retroviridae“. Thesis, Imperial College London, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501764.
Der volle Inhalt der QuelleTextor, Johannes [Verfasser]. „Search and learning in the immune system : models of immune surveillance and negative selection / Johannes Textor“. Lübeck : Zentrale Hochschulbibliothek Lübeck, 2012. http://d-nb.info/1024336921/34.
Der volle Inhalt der QuelleBlaimer, Stephanie [Verfasser], und Edward K. [Akademischer Betreuer] Geissler. „Impact of innate and adaptive immune cells in tumor immune surveillance / Stephanie Blaimer ; Betreuer: Edward K. Geissler“. Regensburg : Universitätsbibliothek Regensburg, 2020. http://d-nb.info/1210729202/34.
Der volle Inhalt der QuelleStrickland, Ian. „The role of immune surveillance in inflammatory reactions in human skin“. Thesis, University of Liverpool, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.307670.
Der volle Inhalt der QuelleBücher zum Thema "Surveillance immune"
Sonnenfeld, Gerald. Cytokines and immune surveillance in humans: Fifth semi-annual progress report. [Washington, DC: National Aeronautics and Space Administration, 1993.
Den vollen Inhalt der Quelle findenSmith, Richard T. Immune Surveillance. Elsevier Science & Technology Books, 2012.
Den vollen Inhalt der Quelle findenCytokines and immune surveillance in humans. [Washington, DC: National Aeronautics and Space Administration, 1994.
Den vollen Inhalt der Quelle findenKishore, Uday, Roberta Bulla und Taruna Madan, Hrsg. Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules. Frontiers Media SA, 2020. http://dx.doi.org/10.3389/978-2-88963-680-8.
Der volle Inhalt der QuelleEpidemiological surveillance of current infections: new threats and challenges. Remedium Privolzhye, 2021. http://dx.doi.org/10.21145/978-5-6046124-2-2_2021.
Der volle Inhalt der QuelleCate, Fred H., und James X. Dempsey, Hrsg. Bulk Collection. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190685515.001.0001.
Der volle Inhalt der QuelleDalbeth, Nicola. Pathophysiology of gout. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199668847.003.0039.
Der volle Inhalt der QuelleSherman, Mark E., Melissa A. Troester, Katherine A. Hoadley und William F. Anderson. Morphological and Molecular Classification of Human Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0003.
Der volle Inhalt der QuelleStewart, Alex G., Sam Ghebrehewet und Peter MacPherson. New and emerging infectious diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198745471.003.0026.
Der volle Inhalt der QuelleBuchteile zum Thema "Surveillance immune"
Mitchison, N. A. „Immune Surveillance“. In Investigation and Exploitation of Antibody Combining Sites, 335. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-5006-4_40.
Der volle Inhalt der QuelleKoga, Tetsuya. „Immune Surveillance against Dermatophyte Infection“. In Fungal Immunology, 443–52. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_22.
Der volle Inhalt der QuelleJung, M. Katherine. „Immune Surveillance and Tumor Evasion“. In Alcohol and Cancer, 193–210. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0040-0_10.
Der volle Inhalt der QuelleMastrangelo, Domenico. „Immune Surveillance and Cancer Pathogenesis“. In Orbital Tumors, 9–20. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1510-1_2.
Der volle Inhalt der QuelleRoy, Moumita. „Alternative Splicing and Immune Surveillance“. In Alternative Splicing and Cancer, 125–44. Boca Raton: CRC Press, 2024. http://dx.doi.org/10.1201/9781003260394-8.
Der volle Inhalt der QuelleHuso, David L., und Opendra Narayan. „Escape of Lentiviruses from Immune Surveillance“. In Virus Variability, Epidemiology and Control, 61–73. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4757-9271-3_5.
Der volle Inhalt der QuelleUenotsuchi, Takeshi, Tetsuo Matsuda, Masutaka Furue und Tetsuya Koga. „Immune Surveillance against Sporothrix schenckii Infection“. In Fungal Immunology, 453–58. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_23.
Der volle Inhalt der QuelleVan den Eynde, B., B. Lethé, A. Van Pel und T. Boon. „Tumor Rejection Antigens and Immune Surveillance“. In Modern Trends in Human Leukemia IX, 279–85. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76829-3_42.
Der volle Inhalt der QuelleChen, Peter W., und Bruce R. Ksander. „Influence of Immune Surveillance and Immune Privilege on Formation of Intraocular Tumors“. In Immune Response and the Eye, 276–89. Basel: KARGER, 2007. http://dx.doi.org/10.1159/000099278.
Der volle Inhalt der QuellePaape, Max J., Kimberly Shafer-Weaver, Anthony V. Capuco, Kaat Van Oostveldt und Christian Burvenich. „Immune Surveillance of Mammary Tissue by Phagocytic Cells“. In Biology of the Mammary Gland, 259–77. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/0-306-46832-8_31.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Surveillance immune"
Dudimah, Duafalia F., Roman V. Uzhachenko, Samuel T. Pellom, Asel K. Biktasova, Mikhail M. Dikov, David P. Carbone und Anil Shanker. „Abstract 3983: Resuscitating immune surveillance in cancer.“ In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-3983.
Der volle Inhalt der QuelleAgudo, Judith, Miriam Merad und Brian D. Brown. „Abstract A168: Quiescent stem cells evade immune surveillance“. In Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-a168.
Der volle Inhalt der QuelleBandyopadhyay, G., H. L. Huyck, S. Bhattacharya, R. Misra, J. Lillis, J. Myers, S. Romas et al. „Respiratory Epithelial Cell Regulation of Pulmonary Immune Surveillance“. In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2130.
Der volle Inhalt der QuelleKuttke, Mario, Emine Sahin, Julia Pisoni, Sophie Percig, Andrea Vogel, Daniel Kraemmer, Leslie Hanzl et al. „Abstract 527: Myeloid PTEN deficiency impairs tumor immune surveillance via immune checkpoint inhibition“. In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-527.
Der volle Inhalt der QuelleRazia, D., H. Abdelrazek, H. Mohamed und A. Arjuna. „De Novo Prostate Adenocarcinoma in a Lung Transplant Recipient: Immune-surveillance or Immune-suppression?“ In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5219.
Der volle Inhalt der QuelleDudimah, Duafalia F., Samuel T. Pellom, Roman V. Uzhachenko, David P. Carbone, Mikhail M. Dikov und Anil Shanker. „Abstract 3642: Cancer therapy by resuscitating Notch immune surveillance“. In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3642.
Der volle Inhalt der QuelleZal, M. Anna, Todd Bartkowiak, Grzegorz Chodaczek, Veena Papanna, Meenakshi Shanmugasundaram und Tomasz Zal. „Abstract 4290: Visualizing immune surveillance in lung metastasis progression“. In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4290.
Der volle Inhalt der QuelleJohnstone, Ricky W. „Abstract IA25: Epigenetic regulation of cancer immune surveillance processes“. In Abstracts: Second AACR Conference on Hematologic Malignancies: Translating Discoveries to Novel Therapies; May 6-9, 2017; Boston, MA. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1557-3265.hemmal17-ia25.
Der volle Inhalt der QuelleVonderheide, Robert H. „Abstract SY09-01: Inflammatory networks and cancer immune surveillance.“ In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-sy09-01.
Der volle Inhalt der QuelleBardelli, Alberto. „Abstract IA18: Inactivation of DNA repair to improve immune surveillance“. In Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-ia18.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Surveillance immune"
Luo, Yunping, und Ralph A. Reisfeld. Priming the Tumor Immune Microenvironment Improves Immune Surveillance of Cancer Stem Cells and Prevents Cancer Recurrence. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2012. http://dx.doi.org/10.21236/ada574527.
Der volle Inhalt der QuelleReisfeld, Ralph R., Debbie Liao und Yunping Luo. Priming the Tumor Immune Microenvironment Improves Immune Surveillance of Cancer Stem Cells and Prevents Cancer Recurrence. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2011. http://dx.doi.org/10.21236/ada553886.
Der volle Inhalt der QuelleBovbjerg, Dana H. Immune Surveillance, Cytokines and Breast Cancer Risk: Genetic and Psychological Influences in African American Women. Fort Belvoir, VA: Defense Technical Information Center, August 2003. http://dx.doi.org/10.21236/ada418645.
Der volle Inhalt der QuelleBovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2001. http://dx.doi.org/10.21236/ada403466.
Der volle Inhalt der QuelleBovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2003. http://dx.doi.org/10.21236/ada427835.
Der volle Inhalt der QuelleBovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2004. http://dx.doi.org/10.21236/ada431795.
Der volle Inhalt der QuelleBovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2002. http://dx.doi.org/10.21236/ada410581.
Der volle Inhalt der QuelleGupte, Jaideep, Sarath MG Babu, Debjani Ghosh, Eric Kasper und Priyanka Mehra. Smart Cities and COVID-19: Implications for Data Ecosystems from Lessons Learned in India. Institute of Development Studies (IDS), März 2021. http://dx.doi.org/10.19088/sshap.2021.034.
Der volle Inhalt der QuelleGupte, Jaideep, Sarath MG Babu, Debjani Ghosh, Eric Kasper, Priyanka Mehra und Asif Raza. Smart Cities and COVID-19: Implications for Data Ecosystems from Lessons Learned in India. Institute of Development Studies, März 2022. http://dx.doi.org/10.19088/sshap.2022.004.
Der volle Inhalt der QuelleGupte, Jaideep, Sarath MG Babu, Debjani Ghosh, Eric Kasper, Priyanka Mehra und Asif Raza. Smart Cities and COVID-19: Implications for Data Ecosystems from Lessons Learned in India. SSHAP, März 2021. http://dx.doi.org/10.19088/sshap.2021.012.
Der volle Inhalt der Quelle